1. Home

Presenter Disclosures

Disclosures are for anything of value received from a commercial interest* or financial relationship** which relates directly or indirectly to the subject of a presentation. All conference presenters are required to declare any financial or industry disclosures during the submission process. Having an interest in or an affiliation with a corporate organization may or may not prevent a speaker from making a presentation. ILCA must be made aware of the relationship in advance.

Circumstances create a conflict of interest when a speaker has an opportunity to affect presentation content about products or services of a commercial interest with which the speaker has a financial relationship.

ILCA will not approve education that is not International Code of Marketing of Breast-milk Substitutes compliant. We require our speakers to state their compliance with the International Code. Should any speaker be found in violation of the International Code, ILCA reserves the right to cancel the presentation and the speaker’s involvement with conference activities and nullify prior agreements.

All speakers must state their disclosures verbally and include them in writing on the disclosure slide at the beginning of their presentation.

When potential conflicts of interest are disclosed that cannot be easily resolved, ILCA’s Compliance Team or the International Code Committee will review the situation and make the final decision on whether the presentation will be included in the program.

*A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

**A relevant financial relationship is a financial relationship in any amount occurring within the past 12 months that creates a conflict of interest.

The speakers and disclosures below are current as of 24 May 2023.

Presenters with No Disclosures

The following presenters have indicated they have no significant financial interest or other relations with the manufacturer(s) of any product(s) or provider(s) of any services they intend to discuss relating to the subject matter of their presentations.

Laura Addati Azza H. Ahmed Tamara Ajeeb Alessandra Angelini Nadrah Arfizah Arfin Altrena M. Ashe Ivy M. Bagley Sabrina Barber Jennifer Bolton Jennifer Day Jolynn Dowling Megan Dunn Paulina Erices Fayrouz Mohammed Essawy Grecia E. Ferreyra Jimi Francis

Emmanuel Gonzalez Elizabeth Hall Melissa Heitzman Naomi Hull Victoria E. Lowe Lisa Mandell Rebecca Mannel BreAnne Marcucci Erin M. McKinley Ezura Madiana Md Monoto Rania Mahmoud Mighawry Maria Miranda Nisha Nair Amanda Ogden Krista Olson Egondu Onuoha

Gina Penka-Corriveau Andini Pramono Alondra Ramírez Javier Ravichagua Wilaiporn Rojjanasrirat Nadine Rosenblum Libby Salmon Margaret C. Saltysiak Daiva Sniukaite Ojas Suniti Vinay Marsha Walker Allyson Wessells Caoimhe Whelan Sau-Pin Won Lu Lu Zhao

Presenters with Commercial Disclosures

The following presenters have indicated the following financial interest or other relationship with a manufacturer and/or provider:

• Elizabeth C. Brooks has relevant financial relationships with Jones & Bartlett: Royalties. All relevant financial relationships have been mitigated. 
• Ellen M. Chetwyndhas relevant financial relationships with International Lactation Consultant Association (ILCA): Honoraria. All relevant financial relationships have been mitigated. 
• Jill Demirci, PhD, RN, IBCLC has relevant financial relationships with Limerick and Pacify Health. Limerick paid for milk storage boxes from them for our research study. Pacify Health  telelactation services were used for research studies. All relevant financial relationships have been mitigated. 
• Lyndsey M. Hookway has relevant financial relationships with Thought Rebellion: Royalties. All relevant financial relationships have been mitigated. 
• Lisette T. Jacobson has relevant financial relationships with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Research Grant or Support. All relevant financial relationships have been mitigated. 
• Suman Kumari Maurya has relevant financial relationships with University Grant Commission of India: Research Grant or Support. All relevant financial relationships have been mitigated. 

Presenters with FDA Clearance Disclosures

The following presenters have indicated the use of pharmaceuticals and/or medical devices: 

• Elizabeth C. Brooks - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 
• Fayrouz Mohammed Essawy - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 
• Grecia E. Ferreyra - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 
• Melissa Heitzman - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 
• Lyndsey M. Hookway - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 
• Ojas Suniti Vinay - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 
• Marsha Walker - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation. 

Conference Disclaimer

Statements of fact or opinion expressed by presenters are solely the responsibility of those presenters. ILCA does not assume responsibility for the accuracy of the material and such material does not represent the official policy, opinion, recommendation, or endorsement of ILCA. The appearance and content of advertisements contained in the final program or registration inserts do not constitute a guarantee or an endorsement of the quality or value of the advertised products or services or of the claims made for them by their advertisers.